Blog
Impact of H. pylori infection and treatment on colorectal cancer
April 2024 A recent study published in the Journal of Clinical Oncology found that Helicobacter pylori infection was associated with...
Fruquintinib in refractory metastatic colorectal cancer
April 2024 Refractory cancer: cancer that does not respond to treatment Fruquintinib (Fruzaqla) is a targeted therapy used in the...
Increasing physical activity may lessen pain intensity for those having lived with cancer
February 2024 For cancer survivors, chronic pain is a potential long-lasting side effect of cancer treatment that can negatively impact...
CADTH recommends that Lonsurf® in combination with bevacizumab be reimbursed for a subset of mCRC patients in Canada
Canada’s Drug and Health Technology Agency (CADTH) Expert Review Committee (pERC) issued its initial recommendation last month to reimburse Lonsurf®...
Navigating the Different Emotions as a Young Person with Cancer
What Emotions Could you Experience During the Diagnosis and Treatment? There is a range of positive and negative emotions you...
Dating During Cancer
Without Cancer, dating can be overwhelming and daunting. Add cancer to the equation and it may feel more complex. It...
